Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference
Two commercialized hematology products, Olverembatinib and Lisaftoclax, drive dual-engine growth with strong…
Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference
- Rapidly transforming into a leading global biopharma company January 09, 2026…
Zealand Pharma to present at the J.P. Morgan Healthcare Conference
January 05, 2026 11:05 ET | Source: Zealand Pharma Press release –…
Total number of shares and voting rights in Zealand Pharma as of December 31, 2025
December 31, 2025 11:05 ET | Source: Zealand Pharma Company announcement –…
Alvotech announces European launch of first-in-market biosimilar to Simponi (golimumab) globally by partner Advanz Pharma
Introduction of AVT05 supported by NHS England tender award in the United…
Freya Pharma Solutions Rebrands as Arletta Pharma Solutions, Marking New Phase in Womens Healthcare Innovation
New name reflects company’s transformation as it advances toward the final phase…
Ascentage Pharma Announces Publication of Olverembatinib Phase Ib Safety, Efficacy and Novel Mechanism Data in Gastrointestinal Stromal Tumors in Natures Signal Transduction and Targeted Therapy
Largest prospective clinical trial to-date in a rare subtype of GIST ROCKVILLE,…
HRV Pharma and MetroChem Forge Strategic CDMO Alliance to Fast-Track High-Value NCE-1 API Development
HYDERABAD, India, Nov. 21, 2025 /PRNewswire/ -- HRV Global Life Sciences (HRV…
OPPI Annual Summit 2025 Highlights the ‘Power of Partnership’ in Driving India’s Pharma Transformation
The Summit highlights how collaboration, trust, and digital innovation are shaping India's…
Axtria Unveils AI-Powered Launch Excellence to Accelerate Success for Emerging Pharma Companies
New integrated offering supports end-to-end brand launches powered by AI, data, and…
